← Research library

Svetinorm: clinical report on a tissue-derived preparation

Comparison in people · 2006

What was studied
85 patients: 47 adjunctive Svetinorm; 38 controls. Chronic hepatitis or care following radiation/chemotherapy.
Main finding
Bilirubin was 20.1 µmol/L after adjunctive Svetinorm and 23.6 µmol/L after conventional care. The table marks a change from the shared baseline of 27.1 µmol/L.

Bilirubin · 20.1 ± 0.8 µmol/L with Svetinorm and 23.6 ± 1.4 µmol/L with conventional care. Shared baseline 27.1 ± 1.2 µmol/L.

Reported findings and study design

47 adults received Svetinorm plus usual care and 38 controls received usual care. The group methods describe two capsules twice daily before meals for 15–20 days.

Population or model 85 patients: 47 adjunctive Svetinorm; 38 controls. Chronic hepatitis or care following radiation/chemotherapy.

Results · Medical Center report, clinical characteristics and liver chemistry table
MeasureResultComparison, timing and statistics
Bilirubin20.1 ± 0.8 µmol/L with Svetinorm and 23.6 ± 1.4 µmol/L with conventional care. Shared baseline 27.1 ± 1.2 µmol/L.
ALT in the report’s stated units43.5 ± 3.5 with Svetinorm and 46.1 ± 3.8 with conventional care. Shared baseline 52.5 ± 4.1. Both arms were marked significant versus baseline.

The table gives a shared baseline and reports significance against baseline.

Source for these results ↗ · Reviewed 2026-11-16

Study limitations and source details

Study limitations

  • A within-group change is not proof of superiority over controls. Mixed diagnoses, co-treatments and incomplete allocation reporting limit interpretation.
  • Commercially reproduced institute report; independent peer review and independent replication are not established by this document.
  • Short-term reporting without a complete adverse-event protocol cannot establish long-term safety. Preparation equivalence to current products or synthetic peptides is unproven.

Source details

Institute report — commercial reproduction

Russian report reproduced on a commercial website; population, comparison and reported outcomes checked. Signed original and full protocol not authenticated.

Sources checked

Citation

Report attributed to · Medical Center, St. Petersburg Institute of Bioregulation and Gerontology

Human comparative studyRussian-language source

St. Petersburg Institute of Bioregulation and Gerontology Medical Center (report attribution). Svetinorm: clinical report on a tissue-derived preparation Institute clinical report (commercial reproduction); 2006 study/report date, not website publication date

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards